Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2023 | U.S. Stem Cell, Inc. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr | CI |
2023 | U.S. Stem Cell, Inc. Wirtschaftsprüfer äußert Zweifel an der Unternehmensfortführung | CI |
5-Tages-Kurse
verzögerte Kurse OTC Markets02.05.2024 | |
---|---|
Kurs | 1.0E-6 $ |
Volumen | 102 475 |
Veränderung | +∞% |
Eröffnung | 0.00 |
Hoch | 0.00 |
Tief | 0.00 |
Performance
1 Tag | -99.00% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Bio-Therapeutische Medikamente
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-99.00% | 0.00% | - | - | 661 | ||
+2.09% | +4.15% | +2.93% | +21.72% | 106 Mrd. | ||
+0.27% | +1.24% | +7.02% | +0.80% | 23.47 Mrd. | ||
-0.83% | +0.20% | -14.60% | -16.58% | 21.9 Mrd. | ||
-0.45% | +1.91% | -7.05% | -27.08% | 18.77 Mrd. | ||
-2.06% | +2.38% | -38.55% | -32.74% | 17.85 Mrd. | ||
+2.42% | +5.05% | -8.83% | -35.24% | 16.78 Mrd. | ||
-2.91% | -2.80% | +5.51% | +42.00% | 14.41 Mrd. | ||
-2.54% | +1.28% | +37.49% | +4.55% | 12.86 Mrd. | ||
+0.38% | +4.55% | +329.39% | +249.56% | 8.78 Mrd. | ||
-0.59% | +3.96% | -24.02% | -33.49% | 8.37 Mrd. | ||
-1.51% | -5.02% | +6.34% | +40.65% | 7.77 Mrd. | ||
-2.08% | +2.77% | -52.30% | -70.24% | 7.67 Mrd. | ||
-0.47% | -1.34% | -0.80% | +28.47% | 7.67 Mrd. | ||
-1.08% | +4.83% | +6.35% | +31.24% | 7.34 Mrd. | ||
-0.02% | +3.00% | -21.82% | +69.93% | 6.84 Mrd. | ||
Durchschnitt | -6.74% | +3.47% | +15.14% | +18.24% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.36% | +3.84% | +6.91% | +12.39% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | 0.00% | ||
2023 | -99.98% | ||
2022 | -20.00% | ||
2021 | -50.82% | ||
2020 | +248.57% | ||
2019 | -78.13% | ||
2018 | -44.83% | ||
2017 | +1’387.18% | ||
2016 | -99.78% | ||
2015 | -91.67% | ||
2014 | +5.00% | ||
2013 | -33.33% | ||
2012 | -66.52% | ||
2011 | -86.42% | ||
2010 | -55.41% | ||
2009 | -25.25% | ||
2008 | -80.20% |
- Börse
- Aktien
- A14X6B Aktie
- Kurse U.S. Stem Cell, Inc.